At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense

Decentralized clinical trials are transforming ophthalmic research by delivering exams directly to patients’ homes, removing one of the most significant barriers to participation — travel and time constraints. This patient-centric approach enables sponsors to reach broader populations, improve retention, and reduce operational strain on research sites. At-home ophthalmic assessments, conducted by trained clinicians using portable diagnostic tools, replicate the quality and rigor of in-clinic exams while offering unmatched flexibility.

For patients, home-based care fosters convenience and engagement, which are essential for adherence and overall trial success. By minimizing logistical challenges, decentralized models accelerate recruitment and streamline workflows, helping studies progress more efficiently without sacrificing data accuracy or regulatory compliance. As ophthalmology trials grow increasingly complex, this strategy provides a practical solution for balancing accessibility, efficiency, and scientific integrity.

Explore how decentralized ophthalmic trials can optimize timelines, enhance patient experience, and deliver robust outcomes for your next study.